VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CANF
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CANFCan-Fite BioPharma Ltd.
$2.83$21M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCANFQuarterly Cash Flow

Can-Fite BioPharma Ltd. (CANF) Quarterly Cash Flow Statement

120+ quarters historyFree accessUpdated daily

Can-Fite BioPharma Ltd. (CANF) quarterly cash flow statement — complete operating, investing & financing history

CANF Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21Q4'20Q3'20
Cash from Operations-2.38M-2.38M-1.8M-1.8M-2.02M-2.02M0-95K95K0263K-135K135K0000000
Operating CF Margin %-2352.48%-2352.48%-1005.87%-1005.87%-1277.21%-1277.21%--48.47%48.47%-133.5%-66.18%66.18%-------
Operating CF Growth %-17.74%-17.74%--1795.26%-2224.21%--100%29.63%-29.63%-----------
Net Income-2.44M-2.44M-1.96M-1.96M-1.98M-1.98M-1.65M-1.76M-1.67M-2.55M-3.02M-2.53M-2.19M-2.43M-4.12M-3.4M-3.22M-1.88M-3.63M-2.58M
Depreciation & Amortization11.5K11.5K3K3K50050000000000000000
Stock-Based Compensation125.5K125.5K84.5K84.5K96.5K96.5K261K-95K95K0263K-135K135K0466K-234K234K0355K-99K
Deferred Taxes00000000000000000000
Other Non-Cash Items203.5K203.5K-194K-194K185.5K185.5K1.39M1.86M1.57M2.55M2.76M2.66M2.06M2.43M3.65M3.63M2.98M1.88M3.28M2.67M
Working Capital Changes-278.5K-278.5K267.5K267.5K-322K-322K00000000000000
Change in Receivables00000000000000000000
Change in Inventory00000000000000000000
Change in Payables00000000000000000000
Cash from Investing1.5M1.5M-1.5M-1.5M2.25M2.25M00000000000000
Capital Expenditures-500-500-500-500-2K-2K00000000000000
CapEx % of Revenue0.5%0.5%0.28%0.28%1.27%1.27%--------------
Acquisitions00000000000000000000
Investments--------------------
Other Investing1.5M1.5M-1.5M-1.5M2.25M2.25M00000000000000
Cash from Financing1.69M1.69M3.36M3.36M0000000000000000
Debt Issued (Net)00000000000000000000
Equity Issued (Net)00000000000000000000
Dividends Paid00000000000000000000
Share Repurchases00000000000000000000
Other Financing1.69M1.69M3.36M3.36M0000000000000000
Net Change in Cash000-4.72M4.72M00-95K95K0263K-135K135K0000000
Free Cash Flow-2.38M-2.38M-1.8M-1.8M-2.02M-2.02M0-95K95K0263K-135K135K0000000
FCF Margin %-2352.97%-2352.97%-1006.15%-1006.15%-1278.48%-1278.48%--48.47%48.47%-133.5%-66.18%66.18%-------
FCF Growth %-17.65%-17.65%--1795.79%-2226.31%--100%29.63%-29.63%-----------
FCF per Share-0.21-0.21-0.21-0.21-0.33-0.33--0.020.02-0.10-0.050.05-------
FCF Conversion (FCF/Net Income)0.97x0.97x0.92x0.92x1.02x1.02x-0.05x-0.06x--0.09x0.06x-0.06x-------
Interest Paid00000000000000000000
Taxes Paid00000000000000000000